Identification and characterization of BRAF⇔TP53 interactions in melanoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Activating BRAF mutations are prevalent in cutaneous melanoma.
• TP53 tumor suppressor inactivation is infrequent despite functional attenuation, suggesting alternative inhibition mechanisms.

Purpose of the Study:

• To investigate the interaction between oncogenic BRAF and TP53.
• To elucidate the mechanism by which BRAF inhibits TP53 function in melanoma.

Main Methods:

• Proximity-dependent proteomic mapping to identify BRAF interactors.
• Analysis of BRAF-TP53 interaction and TP53 subcellular localization.
• Assessment of TP53 activity following DNA damage or pathway disruption.

Main Results:

• A BRAF^V600E-specific interactome was defined, revealing a selective interaction with TP53.
• BRAF^V600E binds the TP53 DNA-binding domain, promoting cytoplasmic localization and suppressing activity.
• TP53 inhibition by BRAF persisted despite DNA damage or pharmacologic intervention.

Conclusions:

• Oncogenic BRAF^V600E functionally inactivates TP53 through direct protein interaction.
• Melanoma can bypass TP53-mediated tumor suppression via BRAF-driven mechanisms, independent of genetic TP53 alteration.